Variables | Crude HR (95% CI) | P-value | Adjusted HR (95% CI)a | P-value |
---|---|---|---|---|
CAD | 0.91 (0.50–1.64) | 0.744 | – | – |
Sex and status of CAD | ||||
 Men without CAD | 1.00 (reference) | – | – | – |
 Men with CAD | 0.92 (0.48–1.75) | 0.793 | – | – |
 Women without CAD | 0.59 (0.29–1.19) | 0.142 | – | – |
 Women with CAD | 0.54 (0.13–2.23) | 0.398 | – | – |
 Age (years) | 1.01 (0.99–1.03) | 0.381 | – | – |
 Men | 1.69 (0.90–3.20) | 0.105 | – | 0.337 |
 Body-mass index (kg/m2) | 0.95 (0.89–1.01) | 0.081 | – | 0.385 |
 Smokerb | 1.00 (0.62–1.60) | 0.999 | – | – |
 Hospital admissions ≥ 2 in the previous year | 2.32 (1.49–3.60) | < 0.001 | 1.94 (1.24–3.04) | 0.004 |
 mMRC ≥ 2 | 1.65 (0.83–3.30) | 0.155 | – | – |
 CAT ≥ 10 | 1.23 (0.54–2.83) | 0.623 | – | – |
 Post-bronchodilator FEV1% predicted | 0.97 (0.96–0.99) | < 0.001 | 0.98 (0.96–0.99) | 0.001 |
Comorbidity | ||||
 Respiratory diseases | 1.24 (0.80–1.93) | 0.334 | – | – |
 Cardiovascular diseasesc | 1.39 (0.90–2.14) | 0.142 | – | – |
 Digestive diseases | 1.35 (0.65–2.81) | 0.416 | – | – |
 Cerebrovascular disease | 1.53 (0.77–3.07) | 0.226 | – | – |
 Endocrine and metabolic diseases | 1.30 (0.70–2.39) | 0.406 | – | – |
 Other malignant tumors | 1.50 (0.37–6.10) | 0.572 | – | – |
Laboratory data during hospitalization | ||||
 PaO2 (mmHg) | 1.00 (0.99–1.01) | 0.540 | – | – |
 PaCO2 (mmHg) | 1.02 (1.00–1.03) | 0.110 | – | – |
 NLR | 1.01 (1.00–1.01) |  < 0.001 | 1.01 (1.00–1.01) |  < 0.001 |
 Eosinophils (%) | 0.95 (0.87–1.03) | 0.210 | – | – |
 NT-proBNP (pg/ml) | 1.00 (1.00–1.00) | 0.936 | – | – |
 CRP (mg/L) | 0.99 (0.99–1.00) | 0.270 | – | – |
 PCT (ng/ml) | 0.84 (0.47–1.51) | 0.563 | – | – |
Treatment during hospitalization | ||||
 SABD | 0.89 (0.54–1.46) | 0.641 | – | – |
 LAMA | 0.90 (0.41–1.94) | 0.780 | – | – |
 LABA | 0.71 (0.33–1.53) | 0.378 | – | – |
 ICS | 0.61 (0.28–1.32) | 0.212 | – | – |
 Nebulized corticosteroids | 1.20 (0.76–1.92) | 0.434 | – | – |
 Systemic corticosteroids | 2.33 (1.50–3.60) | < 0.001 | 2.01 (1.30–3.13) | 0.002 |
 Antibiotics | 1.61 (0.74–3.48) | 0.232 | – | – |